AIとがん研究 ── 大腸がん ── 2026-11-14
大腸がん 1 本。筆頭: A seven-gene signature diagnostic model for early-onset colorectal cancer and the tumor-suppressive role of SLC26A2 via redox modulation.
大腸がんの検診・治療・治験とAI
- A seven-gene signature diagnostic model for early-onset colorectal cancer and the tumor-suppressive role of SLC26A2 via redox modulation.抄録(全訳)掲載誌の IF 相当:4.8(OpenAlex の直近 2 年の平均被引用数・2026-11-12 時点の値、2026-11-13 に取得。正式な IF(Clarivate)ではない)書誌:Yin M, Zhao H, Zhang X, Geng X, Liu Y, Zhang S, et al. A seven-gene signature diagnostic model for early-onset colorectal cancer and the tumor-suppressive role of SLC26A2 via redox modulation. BMC Cancer. 2026 Aug 13;26(1):1387. doi:10.1186/s12885-026-16714-8. PMID: 43009819; PMCID: PMC13753126.確認の範囲:全文を確認